Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Antroids.com
WARNING LETTER
•Antroids.com•April 17, 2020

Antroids.com – FDA Warning Letter, Apr 17, 2020

Record Details

The FDA issued a Warning Letter to www.antroids.com on April 22, 2020, following a review on April 17, 2020, which found the website offering drug products for sale in the United States with claims to mitigate, prevent, treat, diagnose, or cure COVID-19. This action was taken during a declared public health and national emergency related to COVID-19. The FDA determined these products are unapproved new drugs, violating section 505(a) of the FD&C Act (21 U.S.C. § 355(a)), and misbranded drugs under section 502 (21 U.S.C. § 352). Their introduction into interstate commerce is prohibited by sections 301(a) and (d) (21 U.S.C. § 331(a) and (d)). Specific examples cited include "Lopimune 200mg/50mg," "Ritomune 100 mg," "Fluvir 75 mg," and "Antiflu 75mg," all marketed for "Coronavirus Treatment" without FDA approval for COVID-19 uses. The FDA emphasized the inherent risks of unapproved drugs, such as contamination, counterfeiting, and inconsistent active ingredients. The firm was directed to immediately cease sales of these products and, within 48 hours, email COVID-19-Task-Force-CDER@fda.hhs.gov detailing corrective actions, recurrence prevention, and supporting documentation. Failure to comply could result in legal action, including seizure and injunction, and potential detention of products offered for importation.

Company
Antroids.com
Inspection date
April 17, 2020
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Donald D. Ashley (Director)
View Company Profile

ID · 75e0238f-cb18-4774-95be-d212eeaeb70b

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 331(a)21.U.S.C. 355(a)21 U.S.C. 35221 U.S.C. 331(d)21 U.S.C. 321(p)21 U.S.C. 360bbb-3FD&C Act 505(a)FD&C Act 502FD&C Act 301(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Antroids.com
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.